Literature DB >> 16951278

Experimentally-induced acute lung injury: the protective effect of hydroxyethyl starch.

Alessandro Di Filippo1, Marco Ciapetti, Dolores Prencipe, Laura Tini, Andrea Casucci, Riccardo Ciuti, Daniela Messeri, Stefano Falchi, Carlo Dani.   

Abstract

The objective of this study was to evaluate the effects of hydroxyethyl starch, (130/0.4) 6%, compared to Ringer's acetate and modified gelatin on hypoxemia, inflammatory response, and oxidative stress in an experimental model of acute lung injury (ALI). The ALI/Adult Respiratory Distress Syndrome (ARDS) experimental model was produced by a bronchoalveolar saline lavage. Mature New Zealand white rabbits were anesthetized, provided with a tracheostomy and vascular catheters, and randomized to receive 25 ml/kg/hr of Ringer's acetate (group R, n = 7), 25 ml/kg/hr of modified gelatin (group G, n = 7), or 25 ml/kg/hr of hydroxyethyl starch (group S, n = 7). All of the rabbits received mechanical ventilation to maintain the PaCO2 between 35 and 45 mm Hg. Blood gas levels and hemodynamic values were recorded before induction of lung injury (T0) and 10 (T10), 120 (T120) and 240 (T240) min following induction of lung injury. At the same time-points, blood samples were collected to measure the plasma levels of TNFalpha (tumor necrosis factor-alpha) and TBARS (thiobarbituric acid-reactive substances). The experiment yielded the following results: The blood PaO2/FiO2 ratio was higher in group S than in groups R and G at T10, T120, and T240 (p <0.05). In group S, the plasma TNFalpha and TBARS concentrations were lower than in groups R and G at T120 and T240 (p <0.05). In conclusion, rabbits treated with hydroxyethyl starch, (130/0.4) 6%, demonstrated reductions of hypoxemia, inflammatory response, and oxidative lung damage, compared to raabbits treated with Ringer's acetate or modified gelatin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951278

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  6 in total

1.  The therapeutic effects of anti-oxidant and anti-inflammatory drug quercetin on aspiration-induced lung injury in rats.

Authors:  Mehmet Ziya Yilmaz; Aygul Guzel; Aysun Caglar Torun; Ali Okuyucu; Osman Salis; Rifat Karli; Ayhan Gacar; Tolga Guvenc; Sule Paksu; Volkan Urey; Naci Murat; Hasan Alacam
Journal:  J Mol Histol       Date:  2013-10-13       Impact factor: 2.611

2.  Resuscitation with centhaquin and 6% hydroxyethyl starch 130/0.4 improves survival in a swine model of hemorrhagic shock: a randomized experimental study.

Authors:  Zinais Kontouli; Chryssoula Staikou; Nicoletta Iacovidou; Ioannis Mamais; Evaggelia Kouskouni; Apostolos Papalois; Panagiotis Papapanagiotou; Anil Gulati; Athanasios Chalkias; Theodoros Xanthos
Journal:  Eur J Trauma Emerg Surg       Date:  2018-07-13       Impact factor: 3.693

Review 3.  Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Christopher Uhlig; Pedro L Silva; Stefanie Deckert; Jochen Schmitt; Marcelo Gama de Abreu
Journal:  Crit Care       Date:  2014-01-09       Impact factor: 9.097

4.  Role of Nrf2/ARE pathway in protective effect of electroacupuncture against endotoxic shock-induced acute lung injury in rabbits.

Authors:  Jian-bo Yu; Jia Shi; Li-rong Gong; Shu-an Dong; Yan Xu; Yuan Zhang; Xin-shun Cao; Li-li Wu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

5.  The effects of hydroxyethyl starch and gelatine on pulmonary cytokine production and oedema formation.

Authors:  Julia Krabbe; Nadine Ruske; Till Braunschweig; Svetlana Kintsler; Jan W Spillner; Thomas Schröder; Sebastian Kalverkamp; Stephanie Kanzler; Annette D Rieg; Stefan Uhlig; Christian Martin
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

6.  Influence of dextran-70 on systemic inflammatory response and myocardial ischaemia-reperfusion following cardiac operations.

Authors:  Károly Gombocz; Agnes Beledi; Nasri Alotti; Gábor Kecskés; Valéria Gábor; Lajos Bogár; Tamás Koszegi; János Garai
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.